190 related articles for article (PubMed ID: 6286924)
1. Influence of adrenocorticotropin hormone and yohimbine on antidepressant-induced declines in rat brain neurotransmitter receptor binding and function.
Kendall DA; Duman R; Slopis J; Enna SJ
J Pharmacol Exp Ther; 1982 Sep; 222(3):566-71. PubMed ID: 6286924
[No Abstract] [Full Text] [Related]
2. The influence of hormones on drug-induced modifications in neurotransmitter receptor binding.
Kendall DA; Slopis J; Duman R; Stancel GM; Enna SJ
Prog Clin Biol Res; 1982; 79():193-207. PubMed ID: 6124004
[No Abstract] [Full Text] [Related]
3. Rapid desensitization of central beta-receptors and up-regulation of alpha 2-receptors following antidepressant treatment.
Reisine T; Johnson R; Wiech N; Ursillo R; Yamamura HI
Adv Biochem Psychopharmacol; 1982; 31():63-7. PubMed ID: 6282066
[No Abstract] [Full Text] [Related]
4. Antidepressant drugs: effects on beta-adrenergic and serotonineregic receptors.
Frazer A; Lucki I
Adv Biochem Psychopharmacol; 1982; 31():69-90. PubMed ID: 6282067
[No Abstract] [Full Text] [Related]
5. Effect of chronic treatment with tricyclic antidepressant drugs on identified brain noradrenergic and serotonergic neurons.
Svensson TH
Acta Psychiatr Scand Suppl; 1980; 280():121-31. PubMed ID: 6250320
[No Abstract] [Full Text] [Related]
6. [Antidepressant drugs and central monoaminergic receptors].
Asakura M; Tsukamoto T
Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
[TBL] [Abstract][Full Text] [Related]
7. Rapid decrease in rat brain beta adrenergic receptor binding during combined antidepressant alpha-2 antagonist treatment.
Scott JA; Crews FT
J Pharmacol Exp Ther; 1983 Mar; 224(3):640-6. PubMed ID: 6131122
[TBL] [Abstract][Full Text] [Related]
8. The pharmacology of antidepressants at the synapse: focus on newer compounds.
Richelson E
J Clin Psychiatry; 1994 Sep; 55 Suppl A():34-9; discussion 40-1, 98-100. PubMed ID: 7961541
[TBL] [Abstract][Full Text] [Related]
9. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
Wamsley JK; Byerley WF; McCabe RT; McConnell EJ; Dawson TM; Grosser BI
J Clin Psychiatry; 1987 Mar; 48 Suppl():19-25. PubMed ID: 3029045
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic antidepressants on rat brain alpha 2-adrenoceptor sensitivity.
Sugrue MF
Adv Biochem Psychopharmacol; 1982; 31():55-62. PubMed ID: 6282065
[No Abstract] [Full Text] [Related]
11. Effect of repeated restraint stress, desmethylimipramine or adrenocorticotropin on the alpha and beta adrenergic components of the cyclic AMP response to norepinephrine in rat brain slices.
Stone EA; Platt JE; Herrera AS; Kirk KL
J Pharmacol Exp Ther; 1986 Jun; 237(3):702-7. PubMed ID: 3012065
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of antidepressant treatment on brain monoaminergic receptors.
Maggi A; U'Prichard DC; Enna SJ
Eur J Pharmacol; 1980 Jan; 61(2):91-8. PubMed ID: 6101555
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacology of central noradrenergic receptors (author's transl)].
Besson MJ; Reisine TD
Encephale; 1982; 8(2):177-92. PubMed ID: 6286276
[TBL] [Abstract][Full Text] [Related]
14. Modulation of rat brain alpha 2- and beta-adrenergic receptor sensitivity following long-term treatment with antidepressants.
Asakura M; Tsukamoto T; Hasegawa K
Brain Res; 1982 Mar; 235(1):192-7. PubMed ID: 6329413
[TBL] [Abstract][Full Text] [Related]
15. Adaptive changes in functions of brain neurotransmitter receptors, evoked by repeated administration of antidepressant drugs.
Przegaliński E
Acta Physiol Pol; 1987; 38(5):373-85. PubMed ID: 2839008
[No Abstract] [Full Text] [Related]
16. On the mode of action of mianserin.
Leonard BE
Adv Biochem Psychopharmacol; 1982; 31():301-19. PubMed ID: 6282060
[No Abstract] [Full Text] [Related]
17. Interaction between antidepressants and alpha-adrenergic receptor blocking agents.
Zebrowska-Lupina I; Kozyrska C; Stelmasiak M
Pol J Pharmacol Pharm; 1980; 32(5):673-80. PubMed ID: 6115370
[TBL] [Abstract][Full Text] [Related]
18. [5-HT1A/1B receptors, alpha2-adrenoceptors and the post-receptor adenylate cyclase activation in the mice brain are involved in the antidepressant-like action of agmatine].
Jiang XZ; Li YF; Zhang YZ; Chen HX; Li J; Wang NP
Yao Xue Xue Bao; 2008 May; 43(5):467-73. PubMed ID: 18717332
[TBL] [Abstract][Full Text] [Related]
19. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic exploitation of neurotransmitter receptors for the design of novel antidepressant drugs.
Palazidou E; Beer MS; Checkley S; Stahl SM
Drug Des Deliv; 1988 May; 2(4):247-56. PubMed ID: 2908222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
